Skip to main content
. 2021 Jun 28;13(7):978. doi: 10.3390/pharmaceutics13070978

Figure 3.

Figure 3

Pharmacokinetic profile of Ketoprofen in plasma following nasal administration of the drug nanovesicular system (KET-NVS), as compared to oral preparation (KET-PO), each at a drug dose of 14 mg/kg, (n, 5 for each group), (Mean ± SD). ** p < 0.01 KET-NVS vs. KET-PO at 10 min, and 30 min.